Mutagenicity screening of crude drugs with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay. 1982

I Morimoto, and F Watanabe, and T Osawa, and T Okitsu, and T Kada

This paper describes the screening studies of 104 commercial crude drugs for mutagenicity by the rec-assay with Bacillus subtilis as well as the reversion assay with Ames strains TA98 and TA100 of Salmonella typhimurium. The rec-assays showed that 13 water extracts and 27 methanol extracts of the crude drugs were positive. The Ames assays with or without metabolic activation showed that 24 water extracts and 16 methanol extracts were mutagenic. In total, mutagenic activities were found in 45 samples among the 104 crude drugs tested.

UI MeSH Term Description Entries
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D010600 Pharmacology The study of the origin, nature, properties, and actions of drugs and their effects on living organisms. Pharmacologies
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D001412 Bacillus subtilis A species of gram-positive bacteria that is a common soil and water saprophyte. Natto Bacteria,Bacillus subtilis (natto),Bacillus subtilis subsp. natto,Bacillus subtilis var. natto
D012486 Salmonella typhimurium A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. Salmonella typhimurium LT2

Related Publications

I Morimoto, and F Watanabe, and T Osawa, and T Okitsu, and T Kada
June 1991, Planta medica,
I Morimoto, and F Watanabe, and T Osawa, and T Okitsu, and T Kada
November 2000, Mutation research,
I Morimoto, and F Watanabe, and T Osawa, and T Okitsu, and T Kada
September 1984, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
I Morimoto, and F Watanabe, and T Osawa, and T Okitsu, and T Kada
January 1982, Applied and environmental microbiology,
I Morimoto, and F Watanabe, and T Osawa, and T Okitsu, and T Kada
January 1983, Mutation research,
I Morimoto, and F Watanabe, and T Osawa, and T Okitsu, and T Kada
July 1979, Journal - Association of Official Analytical Chemists,
I Morimoto, and F Watanabe, and T Osawa, and T Okitsu, and T Kada
December 1986, Journal of food protection,
I Morimoto, and F Watanabe, and T Osawa, and T Okitsu, and T Kada
August 1999, Phytotherapy research : PTR,
I Morimoto, and F Watanabe, and T Osawa, and T Okitsu, and T Kada
January 1982, Mutation research,
I Morimoto, and F Watanabe, and T Osawa, and T Okitsu, and T Kada
May 1977, Chemico-biological interactions,
Copied contents to your clipboard!